US20250222067A1
University of North Texas Health Science Center
The present invention includes methods of treating ocular fibrosis of the eye in a human subject, the method comprising administering to the human subject in need of treatment a therapeutically effective amount of a prolactin-inducible Protein (PIP) which is capable of inhibiting or reversing the …